Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 29, 2021
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
Mon, June 28, 2021
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
Andrew Cooper Maintained (CDNA) at Strong Buy with Increased Target to $108 on, Jun 28th, 2021
Andrew Cooper of Raymond James, Maintained "CareDx, Inc" (CDNA) at Strong Buy with Increased Target from $90 to $108 on, Jun 28th, 2021.
Andrew has made no other calls on CDNA in the last 4 months.
There is 1 other peer that has a rating on CDNA. Out of the 1 peers that are also analyzing CDNA, 0 agree with Andrew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Andrew
- Matthew Sykes of "Goldman Sachs" Initiated at Strong Buy and Held Target at $95 on, Thursday, June 3rd, 2021
